Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2654

Actual shortage: 249 (9%)
Anticipated shortage: 0 (0%)
Avoided shortage: 9 (0%)
Resolved: 2396 (90%)

Discontinuation Reports

250

To be discontinued: 3 (1%)
Discontinued: 247 (99%)
Reversed: 0 (0%)

Late reports

329 (11%)

Overdue reports

26 (10%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-04-27 2024-04-25 190785
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-06-27 194125
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2023-07-12 194163
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-08 2024-01-08 194191
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-10-06 195078
TEVA-QUETIAPINE XR 150MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-07-05 195118
TEVA-MORPHINE SR 15MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-16 2023-06-21 195210
TEVA-DILTIAZEM XC 360MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195763
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Resolved 2023-06-20 2023-07-05 195827
TEVA-MORPHINE SR 30MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-04 2023-08-04 197169
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-19 2023-12-14 199199
TEVA-QUETIAPINE XR 50MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2023-08-18 199554
TEVA-DILTIAZEM XC 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-07-21 2024-01-11 199717
TEVA-DILTIAZEM XC 180MG TABLET (EXTENDED-RELEASE) Resolved 2023-10-12 2023-12-07 206904
TEVA-TAMSULOSIN CR 0.4MG TABLET (EXTENDED-RELEASE) Actual shortage 2023-11-03 2024-04-11 209148
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2023-11-09 2023-12-07 209672
ACT CLARITHROMYCIN XL 500MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-11 215737
TEVA-DILTIAZEM XC 240MG TABLET (EXTENDED-RELEASE) Actual shortage 2024-01-11 2024-04-25 215740
TEVA-BUPROPION XL 150MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215743
TEVA-BUPROPION XL 300MG TABLET (EXTENDED-RELEASE) Resolved 2024-01-11 2024-02-22 215746

Showing 2601 to 2620 of 2654

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63937
DOCETAXEL INJECTION Discontinued 2018-10-12 2018-10-12 63940
TEVA-CIPROFLOXACIN Discontinued 2018-10-12 2018-10-12 63952
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63967
GEMCITABINE FOR INJECTION Discontinued 2018-10-12 2018-10-12 63970
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64520
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64526
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64529
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64532
ACT ESCITALOPRAM Discontinued 2018-10-17 2018-10-17 64535
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64544
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64547
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64550
TEVA-CIPROFLOXACIN Discontinued 2018-10-17 2018-10-17 64553
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64595
RATIO-MEMANTINE Discontinued 2018-10-17 2018-10-17 64598
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623

Showing 1 to 20 of 250